In addition, a significant body of evidence has revealed that activation of MET in RCC cells promotes proliferation, invasive activity, motility, antiapoptotic activity, and angiogenesis [3,42,84,85,86,87,88]. The gene discussed is MET; the disease is renal cell carcinoma.